NDC 68071-3652-01 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3652
- Requested NDC
- 68071-3652-01
- Package NDCs from labels
- 68071-3652-1, 68071-3652-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | NuCare Pharmaceuticals,Inc. | 2024-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3652-1 | HYDROCHLOROTHIAZIDE | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-3652 | HYDROCHLOROTHIAZIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, 1 package rows | 20240725_1e02787f-ccb5-abc2-e063-6294a90af7c3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | a5525a2a-d2c7-411b-9ffc-0cc4fe77f7c7 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 8808879d-8c7e-45d1-8a49-c05d2cf845d3 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 00f67e1a-6999-4295-9c9f-fcb1ce9711b8 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | ec23c75d-68d5-46d0-be56-b96ddba19ed6 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 1e55800d-f77c-4950-a6d7-2055f4c7ea17 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan medoxomil, amlodipine and hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | 45e975ff-07b1-411a-96ee-a011d1619b1e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f32ce8fe-6cbc-8a15-e053-2995a90a8eec | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b749a6-17ff-e044-e053-2995a90aea28 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c8c79657-a09a-bdb6-e053-2995a90ab673 | 2026-01-01 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f835fa93-6529-c06d-e053-6394a90ad42a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3d801e51-e675-45eb-bc7e-407e610f4009 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 57a2f9bd-8ca5-437e-b911-5207f94cc6ba | 2026-01-01 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | ab8115a0-e96f-7aee-e053-2995a90a6ec0 | 2026-01-01 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f3191ca2-4dbc-01f5-e053-2a95a90a572c | 2026-01-01 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | e3afa83d-c79c-848a-e053-2a95a90ac922 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f32b8809-80e9-18f2-e053-2995a90a5428 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 9ec3d35f-b25d-48f4-926f-f093e402ccde | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db118092-2002-7a55-e053-2a95a90a7b2c | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f331769a-ff11-6c68-e053-2a95a90a493b | 2026-01-01 | Warnings, Adverse reactions | ANDA040702 429503 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db4d84ce-cf51-61dc-e053-2a95a90a2cfd | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.